Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Radek, Trojanec"'
Autor:
Ondrej Kalita, Zuzana Sporikova, Marian Hajduch, Magdalena Megova Houdova, Rastislav Slavkovsky, Lumir Hrabalek, Matej Halaj, Yvona Klementova, Martin Dolezel, Jiri Drabek, Lucie Tuckova, Jiri Ehrmann, Jana Vrbkova, Radek Trojanec, Miroslav Vaverka
Publikováno v:
Current Oncology, Vol 28, Iss 2, Pp 1280-1293 (2021)
This prospective population-based study on a group of 132 resected IDH-wildtype (IDH-wt) glioblastoma (GBM) patients assesses the prognostic and predictive value of selected genetic biomarkers and clinical factors for GBM as well as the dependence of
Externí odkaz:
https://doaj.org/article/f026a67f57ad4e82bce2e57e883a6eb6
Autor:
Alona Rehulkova, Josef Chudacek, Andrea Prokopova, Monika Vidlarova, Jana Stranska, Jiri Drabek, Jana Potockova, Radek Trojanec, Jana Vrbkova, Josef Skarda, Tomas Bohanes, Marek Szkorupa, Benjamin Tolmaci, Jiri Klein, Josef Srovnal, Marian Hajduch
Publikováno v:
Translational Lung Cancer Research. 12:1034-1050
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::436bb3f9575837e7ded119a911cad4c2
https://doi.org/10.21037/tlcr-22-801
https://doi.org/10.21037/tlcr-22-801
Autor:
Erika Kužmová, Vishwas Joshi, Jaroslav Kozák, Lukáš Severa, Lucie Bednarova, Yevgen Yurenko, Juraj Dobiaš, Adam Pecina, Cemal Köprülüoğlu, Petr Jurečka, Martin Lepšík, Ivana Cisarova, Radek Pohl, Piotr Jurkiewicz, Marek Cebecauer, Radek Trojanec, Petr Dzubak, Marian Hajduch, Libuše Lizcová, Karla Svobodová, Zuzana Zemanová, Filip Teplý, Paul E. Reyes-Gutiérrez, Zbigniew Zawada
DNA-binding fluorescent probes are useful tools in cell biology for various applications enabling visualisation and quantification of DNA. Herein, we report on HeliDye1, a novel cationic helicene-like DNA probe, and its versatile usability. HeliDye1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37356cc826c2ae51a273ebd8939f56e2
https://doi.org/10.21203/rs.3.rs-737372/v2
https://doi.org/10.21203/rs.3.rs-737372/v2
Autor:
Jana Vrbkova, Ondrej Kalita, Marian Hajduch, Zuzana Sporikova, Matej Halaj, Lumir Hrabalek, Martin Dolezel, Jiri Ehrmann, Yvona Klementova, Miroslav Vaverka, Magdalena Megova Houdova, Jiri Drabek, Radek Trojanec, Rastislav Slavkovsky, Lucie Tučková
Publikováno v:
Current Oncology, Vol 28, Iss 122, Pp 1280-1293 (2021)
Current Oncology
Volume 28
Issue 2
Pages 122-1293
Current Oncology
Volume 28
Issue 2
Pages 122-1293
This prospective population-based study on a group of 132 resected IDH-wildtype (IDH-wt) glioblastoma (GBM) patients assesses the prognostic and predictive value of selected genetic biomarkers and clinical factors for GBM as well as the dependence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b1b6d4665905217a7021105ca5715f
https://www.mdpi.com/1718-7729/28/2/122
https://www.mdpi.com/1718-7729/28/2/122
Autor:
Josef Srovnal Ed. ), Anna Janošťáková, Viswanath Das, Natálie Kudlová, Jana Stránská, Renata Buriánová, Jana Kotulová, Ermin Schadich, Martin Ondra, Agáta Kubíčková, Soňa Gurská, Pavla Flodrová, Patrik Flodr, Daniela Kurfürstová, Gabriela Kořínková, Mariam Gachechiladze, Tereza Buchtová, Martin Mistrík, Radek Trojanec, Zuzana Šporiková, Jiří Řehulka, Anna Ligasová, Karel Koberna, Jarmila Stanková, Ivo Frydrych, Khushboo Agrawal, Matthew Lacey, Zdeněk Škrott, Vlastimil Mašek, Martina Medvedíková, Ján Gurský, Petr Džubák, Juan B. De Sanctis, Lenka Hrubá, Jana Václavková, Dušan Holub, Tomáš Oždian, Martina Jakoubková, Miloš Petřík, Zbyněk Nový, Narendran Annadurai, Alejandro Carazo, Barbora Lišková, Vladimíra Koudeláková, Vaishali Uniyal, Jiří Drábek, Zuzana Macečková, Hanuš Slavík, Josef Srovnal, Alona Řehulková, Karolína Bartáková, Rastislav Slavkovský
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81f58b62c89602863dbe4640e595f609
https://doi.org/10.5507/lf.22.24460499
https://doi.org/10.5507/lf.22.24460499
Publikováno v:
Clinical Breast Cancer. 18:e841-e850
Triple-negative breast cancer (TNBC) accounts for 15% to 20% of breast cancer cases and is characterized by the absence of estrogen, progesterone, and human epidermal growth factor 2 receptors. Though TNBC is a highly heterogenic and aggressive disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1f30a200140d1e8a1d8ec7781678c61
https://doi.org/10.1016/j.clbc.2018.07.023
https://doi.org/10.1016/j.clbc.2018.07.023
Autor:
Radek Trojanec, M Megova Houdova, O. Kalita, Jiri Drabek, Jana Vrbkova, Z Dwight, Marian Hajduch, V Koudeláková, Miroslava Rabcanova, Sona Mlcochova
Publikováno v:
Klinicka Onkologie. 30:361-371
Mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2) are a promising prognostic biomarker of gliomas. The purpose of our study was to examine the clinical prognostic properties of IDH1/2 mutations in a glioma patient cohort from the Czech Republic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8032c02b66d83cafd7e50747fe0fd298
https://doi.org/10.14735/amko2017361
https://doi.org/10.14735/amko2017361
Publikováno v:
Oncology Letters
To date, no comprehensive prognostic or predictive marker profiling analysis has been performed in association with the age of patients with breast cancer. In the present study, 632 breast cancer tissue samples were analyzed for expression of estroge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::735163b9555d5e6569aaf5ea3b31cc48
https://doi.org/10.3892/ol.2017.6000
https://doi.org/10.3892/ol.2017.6000
Autor:
Zdeněk Kolář, Nora Zlamalova, Gabriela Kořínková, Jiří Ehrmann, Bohuslav Melichar, Radek Trojanec, Marketa Koleckova
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 32(5)
Background Triple-negative breast cancers (TNBCs) are considered a morphologically heterogeneous group of breast carcinomas characterized by the absence or low protein expression of hormone receptors and HER2/neu/ERBB2 with a specific biological beha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ba8fb04fc78a629394862155d4b3ee7
https://pubmed.ncbi.nlm.nih.gov/31610672
https://pubmed.ncbi.nlm.nih.gov/31610672
Autor:
Jana Vrbkova, Radek Trojanec, Miloslava Zlevorová, Miroslav Vaverka, O. Kalita, Marian Hajduch, Magdalena Megova, Lumir Hrabalek, Jiri Drabek, Lucie Tučková
Publikováno v:
Clinical Neurology and Neurosurgery. 144:39-43
Objectives Significant progress in treatment strategies improves the expectations of patients with extracranial cancers. Metastases are the primary consideration in patients with cancer history. In the case of neurologic disorders, the patient should
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c330c011f3c150229a75588ae3f9e42
https://doi.org/10.1016/j.clineuro.2016.02.039
https://doi.org/10.1016/j.clineuro.2016.02.039